Dentsply Sirona (XRAY) Shares Rise 4.4% After Mizuho Analyst Raises Price Target

Dentsply Sirona (NASDAQ:XRAY) shares rose 4.4% to $12.58 on January 21, 2026, after Mizuho analyst Steven Valiquette increased the price target to $14.00 from $13.00, citing improved near-term outlook despite maintaining a "Neutral" rating. The 7.69% price target hike contributed to a 3.8% intraday jump, reflecting investor confidence in potential upside. However, the stock remains volatile, with 15 moves exceeding 5% over the past year. XRAY is up 11.6% year-to-date but trades 38.1% below its 52-week high of $20.31 set in January 2025. Over the past five years, a $1,000 investment would now be worth $218.16. Earlier in the month, Barrington Research’s Michael Petusky reiterated an "Outperform" rating with a $14.00 target, supported by positive trends in dental anesthesia demand. Industry growth is expected as rising procedure volumes fuel need for Dentsply Sirona’s products.